Study of Botulinum Toxin in Patients With Primary Hyperhidrosis
Not Applicable
Completed
- Conditions
- Hyperhidrosis
- Registration Number
- NCT00004480
- Lead Sponsor
- Icahn School of Medicine at Mount Sinai
- Brief Summary
OBJECTIVES:
I. Determine the optimal dose of botulinum toxin necessary to decrease sweating in patients with primary hyperhidrosis.
- Detailed Description
PROTOCOL OUTLINE:
Patients receive injections of botulinum toxin in the clinical trial for 6 months. Patients undergo an iodine starch test and a sympathetic skin response test to assess the efficacy of the drug. Patients also complete questionnaires to evaluate the amount of sweating.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- Not specified
Inclusion Criteria
Not provided
Exclusion Criteria
Not provided
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Mount Sinai School of Medicine
🇺🇸New York, New York, United States